News

The UK Government Announces its First-Ever Grant to the Aeras Global TB Vaccine Foundation


22 Mar 2010
by Working Group

aeras
www.aeras.org

8 million GBP will support the fight against tuberculosis

Rockville, Maryland, USA, March 23, 2010 – Global efforts to combat tuberculosis gained momentum today when the government of the United Kingdom announced generous funding to the Aeras Global TB Vaccine Foundation. The first-ever grant of £ 8,000,000 (approximately US$ 13 million) is a significant show of support for Aeras in its mission to develop new TB vaccines.

“If the international community is serious about tackling HIV and TB we must find a way to break this devastating cycle,” said Mike Foster, the UK Minister for International Development.” That is why the UK is supporting the discovery of a new TB vaccine that is safe for babies born with HIV, and why we are scaling up efforts to reduce the impact of drug resistant strains of TB.”

“Investment by the UK government in our TB vaccine development program is a tremendous boost for Aeras and our partners, especially during such a difficult economic environment,” said R. Gordon Douglas, Jr., MD, Executive Chairman of the Aeras Global TB Vaccine Foundation. “We are grateful to DFID for this generous support.”

> click here to read the press release

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...